- Blood Pressure and Diabetic Nephropathy
- Long-Term Effect of an Education Program (HyPOS) on the Incidence of Severe Hypoglycemia in Patients With Type 1 Diabetes
- Subclinical Hypothyroidism Is Associated With Reduced All-Cause Mortality in Patients With Type 2 Diabetes
- Serotonin 5-HT3 Receptor Antagonist for Treatment of Severe Diabetic Diarrhea
- Immunologic Tolerance to the Insulin Analogue Glulisine
December 25th, 2009 | 
Author: 
Posted in - Diamyd Medical: Diamyd US Phase III Study Well Under WayDiamyd Medical (STO:DIAMB)(Pink Sheets:DMYDY) announces today that one hundred study participants have been included in the ongoing US Phase III study, DiaPrevent. The global Phase III program with the company's lead drug candidate Diamyd® has thereby enrolled more than 430 children newly diagnosed with type 1 diabetes in Europe and the USA...
- Hepatitis C And Insulin Resistance - Surprising FindingsWe have known for several years that Hepatitis C, a common cause of liver cirrhosis and cancer, also makes people three to four times more likely to develop Type 2 diabetes. In studying the insulin resistance of 29 people with Hepatitis C, Australian researchers have confirmed that they have high insulin resistance, a precursor to diabetes...
- Starting Treatment Early Doubles Chance Of Success For People With DiabetesThe sooner people with diabetes start taking metformin, the longer the drug remains effective, according to a Kaiser Permanente study published in the March issue of Diabetes Care, a journal of the American Diabetes Association...
- Link Between Hepatitis C And Insulin Resistance Surprises ScientistsScientists in Australia found that when they studied insulin resistance in people with Hepatitis C little or none of it was in the liver and nearly all the insulin resistance occured in muscle, which surprised them because Hepatitis C is a liver disease that not only leads to cirrhosis and cancer, but also makes people three to four times more likely to d […]